Author

Seth O. Fagbemi

Observed names: Seth Fagbemi, Seth Olusegun Fagbemi

Institution: Marshfield Clinic

Observed institutions: Marshfield Clinic, Marshfield Clinic, Marshfield Clinic Weston Center, Marshfield Clinic

OpenAlex ID: A5091365701

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

2024 · Rahul Aggarwal, Glenn Heller, et al. · Journal of Clinical Oncology · 53

Community experience with bortezomib in patients with multiple myeloma

2007 · Adedayo A. Onitilo, Jessica Engel, et al. · American Journal of Hematology · 5

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

2026 · Young Kwang Chae, Megan Othus, et al. · Journal for ImmunoTherapy of Cancer · 4

Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway

2025 · Zhi Wen, Yidan Wang, et al. · Advanced Science · 4

Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC)

2021 · Adedayo A. Onitilo, Trista J. Stankowski-Drengler, et al. · Clinical Medicine & Research · 3

A randomized phase II trial of folate receptor alpha peptide vaccine in early-stage triple-negative breast cancer.

2026 · Keith L. Knutson, David W. Hillman, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 69

H-index: 4

I10-index: 1